About Worldwide  |     FAQs    |    Careers    |        Media Center  |    Taj Pharmaceuticals  World   |    TAJ Group
       2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Pharmaceuticals API Manufacturer Dextromethorphan Hydrobromide, Dextromethorphan Hydrobromide manufacturer India, Dextromethorphan Hydrobromide product, Dextromethorphan Hydrobromide products, Api preparation, Certificate of Analysis API manufacturer product, Dextromethorphan Hydrobromide anti ulcer product, Certificate of Origin COA Dextromethorphan Hydrobromide COS Dextromethorphan Hydrobromide, pharmaceutical generic, pharmaceutical drug, medical, Dextromethorphan Hydrobromide pharma healthcare, pharma patents, contract MSDS manufacturing Trader Dextromethorphan Hydrobromide pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Dextromethorphan Hydrobromide expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Dextromethorphan Hydrobromide DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Dextromethorphan Hydrobromide ingredients, api, HIV Dextromethorphan Hydrobromide, tablets, capsules, syrup & protein Dextromethorphan Hydrobromide powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Dextromethorphan Hydrobromide gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Dextromethorphan Hydrobromide WHO, UKMHRA Approval

   Pharmaceuticals API List >>>
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us











































 HOME >> API >> Dextromethorphan Hydrobromide

Dextromethorphan Hydrobromide

Chemical Formulas
Dextromethorphan Hydrobromide
pdf api
C18H25NOHBrH2O 370.32

Morphinan, 3-methoxy-17-methyl-, (9α,13α,14α)-, hydrobromide, monohydrate.
3-Methoxy-17-methyl-9α,13α,14α- morphinan hydrobromide, monohydrate

Cas No : 6700-34-1
ATC code R05DA09
PubChem CID 15978238
DrugBank APRD00655
ChemSpider 13109865 Yes

Chemical data
Formula C18H25NO
Mol. mass 271.4 g/mol
SMILES eMolecules & PubChem

Physical data
Melt. point 111 C (232 F)
Pharmacokinetic data
Bioavailability 11%

Molecular Weight: 352.31
Empirical Formula (Hill Notation):
C18H25NO HBr H2O

Suitability meets USP testing specifications

Storage Temperature
Room temperature

Product Information
This product meets USP specifications (Current through USP 23, 4th Supplement), and is traceable to USP Reference Standard lot I

Preserve in tight containers at room temperature. Do not dry; determine water content titrimetrically at time of use. Use promptly. Discard unused material.

 Infrared absorption spectrum
 compares to standard  conforms to USP RS lot I
 Ultraviolet absorption spectrum
100 μg/mL (197U)
absorptivities at 278 nm, calculated on the anhydrous basis, differ by not more
than 3%
conforms to USP RS lot I
 Identification C when dissolved 1 in 200, acidified with nitric acid, the addition of silver nitrate causes a yellowish white precipitate to form. passes
 Specific rotation, [α]325 180 mg/10 ml solution in dioxane (781) specific rotation at 325 nm, calculated on the anhydrous basis, does not differ from standard by more than 1.0% passes
pH 1 in 100 solution (791) between 5.2 and 6.5 6.5
 Water, Method I (921) between 3.5% and 5.5% 4.8%
 Residue on ignition (281) not more than 0.1% passes
 Limit of N,N-dimethylaniline 0.001% passes
 Phenolic compounds no blue-green color develops passes
 Assay - high pressure liquid
 chromatography (621)
not less than 98.0% and
not more than 102.0%

Information Associated with Product :  

Side Effects


trade basketNote: These API/ chemicals are designated as those that are used in the manufacture of the controlled substances and are important to the manufacture of the substances. For any (Control Substance) products Import and Export *** subjected to your country government laws /control substance ACT.
Note /Government Notification: These chemicals are designated as those that are used in the manufacture of the controlled substances and are important to the manufacture of the substances. For any (Control Substance) products Import and Export *** subjected to your country government laws /control substance ACT.
Information:  The information on this web page is provided to help you to work safely, but it is intended to be an overview of hazards, not a replacement for a full Material Safety Data Sheet (MSDS). MSDS forms can be downloaded from the web sites of many chemical suppliers. ,also that the information on the PTCL Safety web site, where this page was hosted, has been copied onto many other sites, often without permission. If you have any doubts about the veracity of the information that you are viewing, or have any queries, please check the URL that your web browser displays for this page. If the URL begins "www.tajapi.com" the page is maintained by the Safety Officer in Physical Chemistry at Oxford University. If not, this page is a copy made by some other person and we have no responsibility for it.
The Controlled Substances Act (CSA) was enacted into law by the Congress of the United States as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970.[1] The CSA is the federal U.S. drug policy under which the manufacture, importation, possession, use and distribution of certain substances is regulated. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs

Taj Pharmaceuticals API Logo

Dextromethorphan Hydrobromide

Api Manufacturer,Export,Supplies,Manufacturing in India

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap


    Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
2004 - 2011 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.